Sectors
GTBP
GT Biopharma, Inc.
0.35
1 x 0.32
1 x 0.39
bid
ask
-
0.01
1.70%
09:25 AM
timesize
| Ytd | -55.15% | |
| 1y | -82.30% |
0.35
day range
0.36
0.26
52 week range
2.29
| Open | 0.36 | Prev Close | 0.36 | Low | 0.35 | High | 0.36 | Mkt Cap | 3.81M |
| Vol | 41.69K | Avg Vol | 1.54M | EPS | -3.71 | P/E | -0.10 | Forward P/E | -0.26 |
| Beta | 0.84 | Short Ratio | 0.71 | Inst. Own | 67.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.43 | 200-d Avg | 0.55 | 1yr Est | 11.00 |
| Income Statement | |||
| Operating Expenses | 2.85M | ||
| Research and Development Expense | 413.00K | ||
| Selling, General and Administrative Expense | 2.44M | ||
| Operating Income | -2.85M | ||
| Interest Expense | 63.00K | ||
| Net Income | -2.83M | ||
| Net Income Common Stock | -3.37M | ||
| Net Income Common Stock (USD) | -3.37M | ||
| Consolidated Income | -2.83M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -2.77M | ||
| Earning Before Interest & Taxes (USD) | -2.77M | ||
| Preferred Dividends Income Statement Impact | 536.00K | ||
| Weighted Average Shares | 30.28M | ||
| Weighted Average Shares Diluted | 30.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.02M | ||
| Cash and Equivalents (USD) | 9.02M | ||
| Current Assets | 10.00M | ||
| Total Assets | 10.00M | ||
| Current Liabilities | 2.42M | ||
| Total Liabilities | 2.42M | ||
| Accumulated Retained Earnings (Deficit) | -726.84M | ||
| Shareholders Equity | 7.58M | ||
| Shareholders Equity (USD) | 7.58M | ||
| Trade and Non-Trade Payables | 253.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 4.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.11M | ||
| Net Cash Flow from Operations | -2.47M | ||
| Share Based Compensation | 46.00K | ||